Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cadrenal Therapeutics Inc CVKD

Cadrenal Therapeutics, Inc. is a biopharmaceutical company. The Company is developing tecarfarin for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions. Tecarfarin has orphan drug and fast track designations from... see more

Bullboard (NDAQ:CVKD)

View:
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Sep 13, 2024 11:20am

CVKD.....My take ....FWIW

This up-coming meeting with FDA could prov to be a major catalyst Caution is needed This has to hold ~ $9.20 or I will say somebody knows something ...no conspiracy here I'm sure I'm wrong  ...more  
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Sep 13, 2024 11:14am

CVKD....LoL my timing is impeccable....R u watching the dip?

now at $10.05 and Green to Red move Cheers !
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Sep 13, 2024 10:26am

CVKD,,,,$12.00 Holla !!!!

Low volume runner.....I'm out ; ) Sold to America
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Sep 13, 2024 9:48am

CVKD......I call this daily action "Walkin the Dog"

Now over $11 which is the highest price since the recent Reverse Split....just sayin Up coming meeting with FDA
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 22, 2024 10:00am

Type B FDA Meeting....FYI

What are Type B FDA meetings?      ...more  
User Avatar Image
(72)
•••
  • IseneschalX
Comment by Iseneschalon Aug 22, 2024 9:15am

RE:CVKD....I hope u all realize this is going to rip to......

Read the previous post which has the todays News Release. Cheers !
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 20, 2024 2:27pm

CVKD......I am now waiting for "The Dip"

Low volume will get this nowhere ; ) Pick your spot....currently trading at $6.87 Cheers !
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 20, 2024 2:11pm

CVKD....I hope u all realize this is going to rip to......

Double digits.....JMHO Cheers !
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 20, 2024 2:06pm

CVKD....here we go Packers here we Go!!!!

$8 holla
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 20, 2024 1:49pm

CVKD....Halted on mini pop.....back now?

Might get a huge uptick....LUDP trading code....volitilty
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 20, 2024 10:32am

CVKD.... 15 : 1 RS effective this a.m

On watch for a dramatic increase in share price....maybe ; ) Currently at $6.20 on 26K shs traded...low vol
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 02, 2024 10:23am

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD): A Promising Antic

https://beyondspx.com/2024/07/31/cadrenal-therapeutics-inc-nasdaqcvkd-a-promising-anticoagulant-candidate-targeting-unmet-needs/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities